Stay updated on Isatuximab Safety, PK, and Efficacy in Multiple Myeloma Clinical Trial
Sign up to get notified when there's something new on the Isatuximab Safety, PK, and Efficacy in Multiple Myeloma Clinical Trial page.

Latest updates to the Isatuximab Safety, PK, and Efficacy in Multiple Myeloma Clinical Trial page
- Check7 days agoNo Change Detected
- Check14 days agoChange DetectedAdded a new revision entry v3.5.0 and removed the older revision v3.4.3 from the Record History.SummaryDifference0.1%

- Check21 days agoChange DetectedA new revision entry (v3.4.3) was added to the history. The previous revision (v3.4.2) was removed.SummaryDifference0.1%

- Check29 days agoNo Change Detected
- Check50 days agoChange DetectedAdded Revision: v3.4.2 and removed the notices about funding lapse and Revision: v3.4.1 on the history page; these are minor history/operational updates. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.4%

- Check57 days agoChange DetectedAdded a government funding/operating status notice banner and updated the page revision from v3.4.0 to v3.4.1.SummaryDifference0.4%

- Check64 days agoChange DetectedUI updates include a glossary display option, color-coding legends for changes, and updated revision/version text. These changes are cosmetic and do not modify core study data or content.SummaryDifference0.5%

- Check71 days agoChange DetectedRevision: v3.3.4 has been added and Revision: v3.3.3 has been removed from the page history display.SummaryDifference0.1%

Stay in the know with updates to Isatuximab Safety, PK, and Efficacy in Multiple Myeloma Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Isatuximab Safety, PK, and Efficacy in Multiple Myeloma Clinical Trial page.